These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Effects of clofibrate and dextrothyroxine singly and in combination on serum lipids. Best MM, Duncan CH. Arch Intern Med; 1966 Aug; 118(2):97-102. PubMed ID: 5329616 [No Abstract] [Full Text] [Related]
4. [Clinical evaluation of a new drug (CH 13437) in the treatment of hyperlipemia]. Arteaga A, Foradori A, Eyzaguirre J, Lira P, Vasquez A, Soto S, Alliende ME, Guzman L. Rev Med Chil; 1970 Oct; 98(10):689-94. PubMed ID: 4927028 [No Abstract] [Full Text] [Related]
5. [Effects of diet changes and use of dextrothyroxine and chlorphenisate on serum lipids]. Arteaga A, Cisternas H, Torres MC, Alliende ME. Rev Med Chil; 1969 May; 97(5):285-90. PubMed ID: 5386042 [No Abstract] [Full Text] [Related]
6. Diet and drugs in the treatment of hyperlipidemias. Med Lett Drugs Ther; 1970 May 15; 12(10):42-4. PubMed ID: 5514225 [No Abstract] [Full Text] [Related]
8. [Clinical trial of C.P.I.B. (clofibrate) in treatment of diabetic hypertriglyceridemia]. Warembourg H, Jaillard J. Lille Med; 1968 Jan 15; 13(1):Suppl:5-8. PubMed ID: 5745605 [No Abstract] [Full Text] [Related]
9. [Clinical study of the effect of ethyl-alpha-p-chlorophenoxybutyrate (clofibrate) in the venous retinal thrombosis]. Cioli S, Nizzola GM. Ann Ottalmol Clin Ocul; 1970 Sep 15; 96(9):477-82. PubMed ID: 5519038 [No Abstract] [Full Text] [Related]
13. Long-term therapy of ischaemic heart disease. Dewar HA. Arzneimittelforschung; 1972 Oct 15; 22(10):1835-40. PubMed ID: 4630017 [No Abstract] [Full Text] [Related]
14. [The value of lipavlon in diabetic retinopathy]. François P, Belervacque A, Turut P. Bull Soc Ophtalmol Fr; 1970 Apr 15; 70(4):568-73. PubMed ID: 5474598 [No Abstract] [Full Text] [Related]
15. Serum lipids in an ambulary diabetic clientele. Effect of therapy with Atromidin (clofibrate). Bergqvist N. Acta Med Scand; 1970 Mar 03; 187(3):213-8. PubMed ID: 5444978 [No Abstract] [Full Text] [Related]
16. Treatment of essential hyperlipidaemia. Fredrickson DS, Levy RI. Lancet; 1970 Jan 24; 1(7639):191-2. PubMed ID: 4189261 [No Abstract] [Full Text] [Related]
17. A comparison of fenofibrate and clofibrate hypolipidemic effects. Daubresse JC. Acta Clin Belg; 1980 Jan 24; 35(4):227-32. PubMed ID: 7015771 [No Abstract] [Full Text] [Related]
18. Platelet function and platelet phospholipids in patients with hyperbetalipoproteinemia. Effect of nicotinic acid and clofibrate. Nordoy A, Rodset JM. Acta Med Scand; 1971 May 24; 189(5):385-9. PubMed ID: 5578488 [No Abstract] [Full Text] [Related]
19. [Etofibrate and clofibrate in double blind study]. Rahlfs VW, Zimmermann H, Safer A. Dtsch Med Wochenschr; 1976 Jul 30; 101(31):1168-9. PubMed ID: 789039 [No Abstract] [Full Text] [Related]
20. [Serum-lipid reducing principles--possibilities for treatment. 6. Indications for the use of clofibrate]. Gustafson A. Lakartidningen; 1970 Dec 14; 67():Suppl IV:75+. PubMed ID: 5511954 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]